Medical/Pharmaceuticals

SCG Cell Therapy Announces FDA IND Clearance of SCG142, a next-generation HPV-specific TCR T cell therapy for patients with HPV-associated solid tumors

SINGAPORE, July 1, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) appl...

2024-07-01 10:56 1992

Transforming Healthcare with AI: YiduTech's Gong Rujing at Summer Davos

DALIAN, China, July 1, 2024 /PRNewswire/ -- "AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry." At the 15th Annual Meeting of the New Champions, ...

2024-07-01 10:17 11184

Pierre Fabre Laboratories announce granting of European marketing authorization for OBGEMSA™ (vibegron) in overactive bladder.

CASTRES, France, June 28, 2024 /PRNewswire/ -- The European Commission (EC) has authorized the marketing of OBGEMSA™ (vibegron) by Pierre Fabre Laboratories for the symptomatic treatment of overactive bladder syndrome in adults, a particularly debilitating condition affecting over 70 million pati...

2024-06-28 23:55 3346

Comprehensively Covering Multiple Myeloma: IASO Bio's GPRC5D CAR-T Product RD118 Receives IND Approval from NMPA

NANJING, China, SHANGHAI and SAN JOSE, Calif., June 28, 2024 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing innovative cell therapies and antibody products, today announces thatthe investigational new d...

2024-06-28 18:59 2148

Hasten Announces Acquisition of 14 Celltrion Legacy Products, Accelerating its Business Expansion in the Pan-Asia Area

SHANGHAI, June 28, 2024 /PRNewswire/ -- Hasten Biopharmaceutical Co., Ltd. (referred to as "Hasten") announced today that it has successfully acquired the asset rights of 14 branded products across Pan-Asia countries and regions from Celltrion, a Korean biopharmaceutical company. According to the...

2024-06-28 16:26 7090

Sirnaomics Announces Completion of STP707 Phase I Clinical Study with Strong Safety Profile and Disease Activity for the Treatment of Pancreatic Cancer Patients

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 28, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or " Sirnaomics"; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, toda...

2024-06-28 13:44 2408

50% ORR: Impressive Clinical Trial Data for Irpagratinib Combined with Atezolizumab in Advanced Hepatocellular Carcinoma Stuns ESMO-GI Congress

SHANGHAI, June 27, 2024 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics) announced that it has presented new phase II clinical data of its highly selective FGFR4 inhibitor irpagratinib (ABSK011) in combination with atezolizumab for the treatment of advanced hepatocellular carc...

2024-06-28 10:30 1543

Innovent Provides Interpretation and Updates on Clinical Data from Mazdutide GLORY-1 Study and General Biomedicine Pipeline

SAN FRANCISCO and SUZHOU, China, June 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ...

2024-06-28 08:00 2511

Neogen® Launches Petrifilm® Automated Feeder to Improve Efficiency of High-Throughput Food Safety Testing

Petrifilm end-to-end solution reduces hands-on enumeration time from 4 hours to 1 minute LANSING, Mich., June 27, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, is helping high-volume food safety testing laboratories implement a more effic...

2024-06-27 20:45 4194

Top 5 Global Biotech Company Goes Live with LifeSphere® MultiVigilance and Reporting & Analytics Solution

* The top-tier life sciences company will standardize its Safety operations on the cloud-powered technology platform, LifeSphere, which is propelling life sciences GenAI use cases. * The company will use LifeSphere MultiVigilance and Reporting & Analytics Solution to process some600,000 adver...

2024-06-27 20:00 2033

Geek+ implements first Tote-to-Person project in Italy for pharmaceutical chain

DUSSELDORF, Germany, June 27, 2024 /PRNewswire/ -- Geekplus, the global leader in mobile robot and smart logistics solutions, in collaboration with SSI Schaefer has implemented its Tote-to-Person solution inItaly for Dr. Max, one of Europe's leading pharmaceutical chains. This is the first Tote-to...

2024-06-27 17:00 1679

US FDA New Drug Application Approval of Ohtuvayre™ (ensifentrine) for the Maintenance Treatment of COPD

SHANGHAI, June 27, 2024 /PRNewswire/ -- Nuance Pharma's global partner Verona Pharma plc (Nasdaq: VRNA), announces the US Food and Drug Administration ("FDA") approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. Ohtuvay...

2024-06-27 13:59 2157

Amsino Medical Group announces transformational investment from Novo Tellus

POMONA, Calif., June 27, 2024 /PRNewswire/ -- Amsino Medical Group ("Amsino"), a global provider of medical consumable devices, is pleased to announce the closing of a substantial investment by Novo Tellus, a leading investment firm specialising in long-term investments in the global supply chain...

2024-06-27 12:27 1776

Easy and Fast "Cat Urine Test Kit" for Early Detection of Kidney Disease, Gallstones, and Cystitis

BANGKOK, June 27, 2024 /PRNewswire/ -- Researchers from Chula Faculty of Science invented an easy-to-use "Cat Urine Test Kit" to screen for the risk of kidney disease, gallstones, and cystitis in cats. The test kit provides fast and accurate results, so cats can be ...

2024-06-27 10:00 2031

Harbour BioMed Announces Resubmission of Biologics License Application for Batoclimab to NMPA for Treatment of Generalized Myasthenia Gravis

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, June 26, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...

2024-06-27 07:08 1714

Suvoda Expands its Clinical Trial Offering with the Introduction of ePatient

With the focus on improving patient experience and reducing burden on sites  PHILADELPHIA, June 27, 2024 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases, ...

2024-06-27 07:00 1640

The Future of Telehealth Relies on Seamless UC&C Monitoring

* IR launches a healthcare bundle to meet the demands of proactive communication monitoring in healthcare organizations. SYDNEY, June 26, 2024 /PRNewswire/ -- IR (ASX:IRI), a leading provider of global performance management and analytics for Unified Communications and Collaboration (UC&C), h...

2024-06-26 21:30 2112

HUADONG MEDICINE Announces Positive Phase I Results for Innovative Oral Small Molecule GLP-1 Receptor Agonist HDM1002

HANGZHOU, China, June 26, 2024 /PRNewswire/ -- HUADONG MEDICINE, through its wholly-owned subsidiary Hangzhou Zhongmei HuaDong Pharmaceutical CO. LTD (Zhongmei HuaDong), has recently announced positive results from Phase I clinical trials of its innovative oral small molecule GLP-1 receptor agoni...

2024-06-26 21:05 2495

bioSeedin Expanded Global Licensing and Partnership Opportunities at 2024 BIO International Convention

NEWARK, Del., June 26, 2024 /PRNewswire/ -- bioSeedin, a flourishing global licensing and consulting platform, captivated attendees as an esteemed exhibitor at the BIO International Convention, the preeminent global biotech gathering. This prestigious event unfolded inSan Diego, spanning from Jun...

2024-06-26 21:00 1235

Neurophet to present brain stimulation simulation study at OHBM 2024

- Presents a poster identifying tDCS effects for patients with AD and cognitively normal people - Showcases brain imaging treatment planning software for electric brain stimulation Neurophet tESplan Plus SEOUL, South Korea, June 26, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI...

2024-06-26 21:00 1876
1 ... 49505152535455 ... 610

Week's Top Stories